Acusphere, Inc.
OTC: ACUS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- William I. Ramage D.Phil
- Employees
- 50
- Headquarters
- Watertown, United States
- IPO year
- 2003
- Market cap
- $49.0
- Website
- https://www.acusphere.com
Loading ACUS…
Loading profile data…Frequently asked questions about ACUS
What does Acusphere, Inc. (ACUS) do?
Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injecta...
Where does ACUS trade?
Acusphere, Inc. (ACUS) trades on the Other OTC.
What sector is ACUS in?
Acusphere, Inc. (ACUS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Acusphere, Inc.?
William I. Ramage D.Phil is the chief executive officer of Acusphere, Inc. (ACUS).
Where is Acusphere, Inc. headquartered?
Acusphere, Inc. is headquartered in United States.
Does ACUS pay a dividend?
Acusphere, Inc. (ACUS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACUS go public?
Acusphere, Inc. (ACUS) completed its initial public offering in 2003.